Trademark: 97501179
Word
GP CR THERAPEUTICS
Status
Pending
Status Code
730
Status Date
Wednesday, January 17, 2024
Serial Number
97501179
Mark Type
3000
Filing Date
Wednesday, July 13, 2022
Published for Opposition
Tuesday, June 6, 2023

Trademark Owner History
GPCR Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical products for the treatment of cancer, and mobilization/collection of cells, including stem cells and immune cells; biological preparations for the treatment of cancer, and mobilization/collection of cells, including stem cells and immune cells
10 Medical diagnostic apparatus for detecting cancer, and mobilization/collection of cells, including stem cells and immune cells
The mark consists of the letters "GP" on top of the letters "CR" next to the word "therapeutics", all of which appear on top of a repeating pattern of generally horizontal lines that each begin on the left with a concave curved portion, followed by a combination of angled, straight, and zig zag portions, and ending with another straight portion. The lines are oriented on top of each other and do not intersect.
Color is not claimed as a feature of the mark.
"GPCR THERAPEUTICS"

Trademark Events
Jan 19, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2024
Sou Extension 1 Granted
Jan 17, 2024
Sou Extension 1 Filed
Jan 17, 2024
Sou Teas Extension Received
Aug 1, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Published For Opposition
May 17, 2023
Notification Of Notice Of Publication E-Mailed
May 2, 2023
Approved For Pub - Principal Register
May 2, 2023
Examiner's Amendment Entered
May 2, 2023
Notification Of Examiners Amendment E-Mailed
May 2, 2023
Examiners Amendment E-Mailed
May 2, 2023
Examiners Amendment -Written
Apr 27, 2023
Assigned To Examiner
Aug 3, 2022
Notice Of Design Search Code E-Mailed
Aug 2, 2022
New Application Office Supplied Data Entered
Jul 16, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24